chevron_leftBack
As of 17 June 2026, AIOBIO Co., Ltd. has a market cap of $4.44M USD, ranking #44969 globally and #2729 in South Korea.
It ranks #3984 in the Healthcare sector, and #840 in the Medical Devices industry.
Key Stats
Market Cap
$4.44MUSD
6.71B KRW
Company Profile
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 5.2% | 6.5% | -6.3% | -39% | -26% | -38% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
447690
(주)아이오바이오
ISIN: KR7447690009
Shares Out.:
Shares Outstanding:
2.63M1
Shares Float:
2.301M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
2,625 KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
KRX: 214150
|
$2.49B
56K%
3.75T KRW
|
28.7
|
|
KRX: 458870
|
$1.24B
28K%
1.86T KRW
|
114.8
|
|
KRX: 491000
|
$1.2B
27K%
1.81T KRW
|
-
|
|
KRX: 290650
|
$1.15B
26K%
1.74T KRW
|
-
|
|
KRX: 096530
|
$765.32M
17K%
1.16T KRW
|
23.9
|
|
KRX: 214430
|
$536.4M
12K%
809.64B KRW
|
83.3
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
4M%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
4M%
|
56.7
|
|
NYSE: ABT
|
$159.07B
4M%
|
25.6
|
|
NYSE: DHR
|
$126.55B
3M%
|
34.7
|
|
NYSE: SYK
|
$120.69B
3M%
|
38.3
|
|
NYSE: MDT
|
$101.9B
2M%
|
22.2
|
chevron_leftBack